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 Experimental findings are limited concerning efficacious procedures for facial 
reanimation following persistent idiopathic facial paralysis or paresis.  Additional research 
examining the use of real-time integrated electromyography (iEMG) biofeedback for young 
children with persistent idiopathic facial paralysis is one approach to further understand the 
efficacy of electrophysiology biofeedback techniques in facial reanimation for this age group and 
etiology.  iEMG research has applications in interventions for pathology of nerves and muscles 
affecting animation of the face.  The proposed clinical case study will adopt real time iEMG 
visual biofeedback to facilitate facial reanimation in a preadolescent child.  Quantitative 
measurements will determine orofacial muscle activation levels across 3 months of weekly facial 
gesture training sessions in an academic clinical speech pathology setting.  This study found 
positive main effects on mid-face and perioral iEMG activation patterns related to biofeedback 
session number, muscle group, and between affected and unaffected sides of the face.  According 
to clinical examination, the child participant demonstrated increased reanimation in the affected 
mid-face related to session number with the new appearance of facial dimpling, oral angle 
retraction during smile, and observed changes in extraocular posture and movement of the right 
eyelid, also noted by her physician and dentist.  This study illustrated the potential importance of 
real time biofeedback training for facial reanimation and the efficacy of an electrophysiological 
 
monitoring system to quantify and display facial muscle activation patterns to enhance facial 
movement during emotive gestures.  
Key words: communication sciences and disorders, biofeedback, orofacial muscles, 
electromyography, congenital facial paralysis 
 i 
Acknowledgements 
This study was funded, in part, by the Barkley Trust Foundation at the University of Nebraska-
Lincoln and the Communication Neuroscience Laboratories (CNL).   
 Thank you to Dr. Steven Barlow. 
 Thank you to the committee Dr. Judy Harvey and Dr. Kevin Pitt.  
 Thank you to the amazing participant and family.  
 Thank you to SLPA cohort members.  
 Thank you to family and friends for support throughout this process.  
 ii 
TABLE OF CONTENTS 
List of Figures.................................................................................................................................iii 
List of Tables..................................................................................................................................iv 
Introduction......................................................................................................................................1 
 Neuromuscular Anatomy of the Face..................................................................................1 
 Etiology of Facial Palsy.......................................................................................................3 
 Treatment strategies for patients with facial palsy..............................................................5 
 Biofeedback.........................................................................................................................7 
 Study Aims..........................................................................................................................8 
Methods............................................................................................................................................8 
 Electromyography..............................................................................................................12 
 Statistical Processing.........................................................................................................16 
Results............................................................................................................................................16 
Discussion......................................................................................................................................22 
Limitations of this Clinical Study..................................................................................................24 
References......................................................................................................................................26 
APPENDIX I.................................................................................................................................30 
APPENDIX II................................................................................................................................31  
 iii 
LIST OF FIGURES 
Figure 1. Lateral view of the facial muscles....................................................................................1 
Figure 2. Course of the facial nerve.................................................................................................2 
Figure 3. Course of the trigeminal nerve.........................................................................................2  
Figure 4. Bell’s palsy presentation...................................................................................................4 
Figure 5. Participant presentation of facial palsy...........................................................................10 
Figure 6. Participant presenting facial paralysis for “smile” gesture.............................................11 
Figure 7. Hydrogel surface electrodes...........................................................................................13 
Figure 8. Facial electromyographic (EMG) recording array.........................................................14 
Figure 9. Stimulus prompt pictures................................................................................................15 
Figure 10. Normalized iEMG for R-midface.................................................................................18 
Figure 11. Normalized iEMG for L-midface.................................................................................19 
Figure 12. Normalized iEMG for R-lip perioral............................................................................20 
Figure 13. Normalized iEMG for L-lip perioral............................................................................21  
 iv 
LIST OF TABLES 
Table 1. Clinical efficacy for various etiologies of facial palsy......................................................6 
Table 2. Presentation schedule.......................................................................................................15 
Table 3. iEMG ‘smile’ motor expression data...............................................................................17  
 1 
 
Clinical Case Study:  The Effects of Real-time iEMG Biofeedback on Facial 




 Facial paralysis or paresis is a rare condition that affects approximately 25-30 per 
100,000 individuals per year in the United States (Bleicher et al., 1996) and is further 
confounded by varying etiologies, symptoms, and subtypes (de Freitas et al., 2016).  Deficits in 
facial animation create variable difficulties for individuals, including diminished functional 
movements (e.g., speech, eating, sucking, eye closure, blowing, 
conveying emotions, etc.).  The functional deficits that arise 
from diminished movements may impact an individual’s ability 
to engage in daily activities and communicate with others.  
Therefore, treatment options are necessary to increase 
reanimation and quality of life for individuals with facial 
palsies.  
 
Neuromuscular anatomy of the face. 
The muscles of the face (Figure 1) produce functional 
movements through their innervation by the facial nerve (CN 
VII) and the trigeminal nerve (CN V).  Upper face levator (frontalis and procerus) and depressor 
(corrugator suupercilii, depressor supercilii) muscles participate in raising and depressing the 
eyebrows.  Midface levator muscles (levator labii superioris, zygomaticus major, zygomaticus 
minor, levator anguli oris) participate in the movement of the oral angle, upper lip and cheeks 
(i.e., smile).  Other midface muscles include the buccinator and the masseter which participate in 
Figure 1. Lateral view of the facial 
muscles (adapted from Marur et al., 
2014). 
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mastication.  Finally, the muscles of the lower face include sphincter (orbicularis oris superior, 
orbicularis oris inferior), retractor (risorius), and depressor (mentalis, depressor labii inferioris) 
muscles.  These muscle groups are involved in 
various movements of the face.  For instance, the 
midface levators and the lower face retractor 
participate in smile production, the obicularis oris 
muscle is involved in lip rounding and protrusion, 
and lower face depressors and the levator labii 
superioris participate in frowning expressions (Marur 
et al., 2014).  Through careful observation and 
measurement of facial movements, one can assess 
innervation status of the muscles by CN VII 
and possibly identify pathology.  Upper motor 
neurons originating in the face motor cortex 
descend through the corticobulbar efferent 
system to monosynaptically influence lower 
motor neurons in the facial motor nucleus 
located in the pons of the brainstem.  The 
facial nerve then exits the brainstem, follows the 
cerebellopontine angle, and enters the internal auditory meatus (Figure 2).  From there, it 
separates into 5 branches which then innervate the muscles of the face.  For the purposes of this 
study, the trigeminal nerve (CN V) is also highlighted.  A large role of CN V is to relay afferent 
sensory information from the face to the cortex (Kamel & Toland, 2001).  The trigeminal nerve 
Figure 3. Course of the trigeminal nerve (Kamal & 
Toland, 2001).  
Figure 2. Course of the facial nerve 
(Medicalartlibrary.com, 2017).  
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has three branches and is largely involved in relaying afferent sensory information from the face 
and tongue to the cortex (Figure 3).  The mandibular branch of CN V participates in some motor 
innervation of the muscles for mastication (Feroze et al., 2017).  
 
Etiology of facial palsy. 
There is clearly a multitude of muscles and branches of the facial nerve that participate in 
facial kinematics, and their coordination is dependent on proper functioning of all elements.  
Therefore, facial paralysis or paresis may result from varying etiologies.  It is imperative that 
when identifying individuals with facial paralysis, researchers understand the underlying causes 
and categories that it denotes.  Of these etiologies, idiopathic facial paralysis is the most common 
(e.g., Bell’s palsy, paralysis without a known cause) comprising 60-75% of cases.  Trauma of 
CN VII or damage to its nucleus is reported to cause 2-5% of cases in population studies (Atolini 
et al., 2009; Cha et al., 2008).  Infection or disease (e.g., Epstein-Barr virus) account for many of 
the cases of Bell’s palsy, which is due to the unknown etiology at the onset of diagnosis and then 
identification of the infection later.  Other causes include genetic syndrome (e.g., Moebius 
syndrome) present in 1/150,000 births, developmental anomalies of CN VII (Jemec et al., 2000; 
Nordjoe et al., 2018), cancer (e.g., meningioma at the cerebellopontine angle) 5-6% of cases of 
CPA meningiomas result in facial palsy (Sam et al., 2017), and brainstem stroke (Aranha et al., 
2017; Deep et al., 2016; Kim et al., 2017; Kouri et al., 2018; Vogelnik & Matos, 2017).  For 
facial palsies with a known cause, one can identify a course of treatment such as surgery, 
medication, or physical therapy (Álvarez-Argüelles et al., 2019; Sam et al., 2017), however in 
others with idiopathic facial paralysis, there is a less direct path to intervention that allows 
reanimation of the facial nerve.  
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Similarly, on how facial paralysis can have etiologies ranging from congenital to 
acquired (Corral-Romero & Bustamante-Balcárcel, 1982; Kasahara et al., 2017), symptomology 
also differs based on etiology and can vary in degrees of paralysis and function.  Individuals with 
facial paralysis may present with bilateral or unilateral paralysis due to varied causes (Hamizan 
et al., 2012; Jemec et al., 2000; Messana et al., 2018).  For instance, diffuse damage to the 
brainstem may present in bilateral facial paralysis if both nuclei are affected, whereas infection 
to CN VII may present unilaterally.  Additionally, unilateral 
damage alone can yield various presentations of paralysis.  
This is perhaps best illustrated by the difference between 
upper motor neuron damage and subsequent facial 
impairment versus damage or inflammation to CN VII and its 
subsequent facial paralysis.  While these both create facial 
paralysis, often unilateral damage to upper motor neurons in 
the sensorimotor cortex will result in contralesional impairment 
of the lower 2/3rds of the face, with droop of the oral angle with 
intact movement of the upper 1/3 of the face.  Alternately, with lower motor neuron damage 
including the facial motor nucleus and/or facial nerve, it is more likely to observe paresis of the 
entire ipsilateral face affected including forehead, maxillary, extraocular and perioral muscles 
(Sam et al., 2017).  Symptomology and presentation of facial paresis is important for 
intervention procedures.  Furthermore, etiology can also predict the longevity of symptoms.  For 
example, patients who manifest Bell’s palsy often recover facial movement within weeks to 
months.  Previous studies suggest that Bell’s palsy is the most prevalent form of facial paresis or 
paralysis (Figure 4).  However, it is evident that many studies classify facial palsy as Bell’s palsy 
Figure 4.  Bell’s palsy presentation 
(columbianeurology.org, 2015)   
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despite the lack of confirmatory evidence.  It is later when researchers identify recovery in the 
participants, spontaneously or through interventions, that they can confirm the diagnosis of 
Bell’s palsy (Aranha et al., 2017; Khair & Ibrahim, 2018; Poloni et al., 2018; Viteri et al., 2015).  
Alternately, other causes such as meningioma or a persistent form of facial paresis typically do 
not result in recovery of facial movement (Deep et al., 2016; Sam et al., 2017).  
 
Treatment strategies for patients with facial palsy.   
As previously mentioned, due to the variable presentation and symptomology, idiopathic 
facial paralysis presents a further issue regarding reanimation procedures.  Many case studies 
identifying individuals with persistent idiopathic facial paralysis do not report consistent and 
noninvasive procedures for reanimation (Nordjoe et al., 2018).  The most common types of 
treatment for varying etiologies are given in Table 1.  Many of these treatments are specific to 
known causes and not sufficient for treating persistent idiopathic facial paralysis.  However, after 
paralysis is deemed idiopathic due to lack of confirmatory signs for obvious etiologies (e.g., 
trauma, cancer, stroke), an individual may be put on a course of anti-inflammatory medication.  
If a medication is effective and the individual recovers, the researchers then have confirmatory 
evidence for Bell’s palsy.  Although it appears that some medications were effective for 
reanimation of idiopathic cases, they are not effective for persistent idiopathic cases and should 
















Complete recovery in 4/5 
cases; 1 persistent 
 
Asymmetry remains @ 1 yr 
 
Complete recovery after 1 mo 
Vogelnick & Matos (2017) 
 
Kouri et al. (2018) 
 









2 wk recovery  
 
2 mo recovery 
 
Recovery @ 9 mos 
Khair & Ibrahim (2018) 
 
Álvarez-Argüelles et al. 
(2019) 







Increased FGS score 
 
Decreased asymmetry 
Aranha et al. (2017) 
 





No improvement Sam et al. (2017) 
 
 
Overall, there is an increased need for a more consistent procedure to better treat various 
facial paralyses and symptomologies.  Furthermore, a procedure has little validity until a valid 
and reliable measure is established to identify and report characteristics of the facial paralysis as 
well as changes that may occur over the course of treatment.  One of the common clinical 
measures for defining facial paralysis involves facial grading systems (FGS) to classify and 
subjectively score movement capabilities during facial gestures (i.e., smile, etc.)  (Duarte-
Moreiera et al., 2018; Kasahara et al., 2017; Lee et al., 2015; Pourmomeny et al., 2013).  Many 
scoring systems involve observation of the face resulting in qualitative reports (Lee et al., 2015).  
The Sunnybrook Facial Grading Scale (FGS) focuses on three areas of observation: resting 
symmetry, symmetry of voluntary movement, and synkinesis (defn: synkinesis is a neurological 
symptom in which a voluntary muscle activation causes simultaneous involuntary contraction of 
other muscles).  These areas are rated using a Likert scale in which the movements and 
Table 1.  Clinical efficacy for various etiologies of facial palsy. 
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symmetry are rated as either within normal limits or highly impaired (Neely et al., 2010).  An 
FGS that uses a common ruler to measure static facial postures is the House-Brackmann FGS 
which compares movements of the affected side to the non-affected side.  The clinician rates the 
patient between grade I [normal] to grade VI [total paralysis] (House & Brackmann, 1985).  
Other forms of measurement include photogrammetry which involves the comparison of 
orofacial flesh points estimated from still images (Filho et al., 2015; Nakamura et al., 2003).  
These qualitative scales to grade the degree and location of facial paralysis at baseline and after 
intervention are often inconsistent and influenced by human error.  Therefore, it is important that 
a physiologically-based intervention for facial reanimation be paired with an objective and 
reliable form of measurement.  In utilizing a more structured procedure, the clarity of progress 
and results is easier to convey.  One such instrumental technique that may yield quantification of 
facial movement is electrophysiology (i.e., surface electromyography – sEMG) in a visuomotor 
tracking paradigm which will allow the clinician-investigator to explore the correlation between 
facial muscle activation patterns during baseline evaluation, and repeated-measures during the 
course of therapeutic biofeedback to retrain facial muscle activation patterns.    
 
Biofeedback. 
Self-awareness is a skill that many individuals have difficulty mastering. When 
considering a clinical setting, clients often have difficulty self-monitoring and require training to 
increase their awareness.  Biofeedback measures are proven to increase awareness of movements 
and provide a method for increasing volitional control (Corral-Romero & Bustamante-Balcárcel, 
1982).  Feedback procedures range in modality from use of a mirror (Corral-Romero & 
Bustamante-Balcárcel, 1982, Lee et al., 2015) to tape on the skin allowing participants to be 
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cognizant of movements (Kasahara et al., 2017).  These procedures, while providing a form of 
feedback, do not yield specific and objective information regarding participant movements.  
Furthermore, they do not lend to creating operational participant target responses.  Biofeedback 
occurs in many forms including use of a video game to increase volitional control of a muscle 
(Maia et al., 2019) and EMG output paired with auditory feedback (Arpa & Ozcakir, 2019).  
Researchers have sought to identify the effectiveness of biofeedback procedures in decreasing 
synkinesis, increasing reanimation following paralysis due to nerve dysfunction, and reanimation 
following paralysis due to muscle dysfunction (Duarte-Moreiera et al., 2018, de Freitas et al., 
2016, Pourmomeny et al., 2013).  Given trained participants, biofeedback has yielded effective 
results in reanimation of orofacial structures (de Freitas et al., 2016).  However, there is vast 
heterogeneity in the procedures that researchers use and the reanimation results due to facial 
nerve deficits (Duarte-Moreiera et al., 2018).  Furthermore, little research has been conducted on 
iEMG biofeedback procedures for young children with congenital and persistent facial paralysis.  
Study Aims.   
The goal of the present clinical study was to assess the efficacy of real-time integrated 
EMG visual biofeedback during repeated ‘smile’ gesture productions over 11 weeks in the 
treatment of a 3-year old child with a congenital form of hemifacial paralysis.   
 
Methods 
A 3-year-old female presented to the Barkley Speech Language and Hearing Clinic 
(BSLHC) at the University of Nebraska with congenital right facial paralysis.  The parents 
indicated that the unilateral right side facial paralysis was congenital of unknown etiology as 
depicted in Figure 5.  Facial paralysis presented at birth following an uncomplicated pregnancy 
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and delivery.  The participant exhibited an asymmetric cry and difficulty with feeding that was 
first reported by the obstetrician.  Subsequently, the participant was referred to several specialists 
including an otolaryngologist who obtained MRI images of the temporal bone and facial 
skeleton, pediatric plastic surgeon, and a neurologist.  The participant underwent MRI with and 
without contrast at 13-months-old.  Images revealed otomastoiditis yielding opacification of the 
right mastoid and middle ear which prevented effective evaluation of the right facial nerve 
course at that time.  Etiology of the opacification was suspected to be recent otitis media.  The 
diagnoses concluding this visit were Bell’s palsy, unspecified mastoiditis of the right ear, and 
chronic sinusitis.  Two months following neuroimaging, the participant visited a pediatric plastic 
surgeon who reported a complete right facial paralysis with slight movement near the oral 
commissure.  The plastic surgeon suggested a follow up appointment a couple years later to 
discuss treatment options including free tissue transfer reconstruction after the participant turns 
5-years-old.  One month later, a neurologist visit revealed no other cranial nerve deficits apart 
from right facial palsy.  The neurologist assessed that the palsy was likely due to utero pressure 
or trauma instead of syndrome due to facial nerve symptom presentation only.  Upon 
presentation to BSLHC, mobility was most noticeably impaired in the right mid-face, with 
reduced eye closure and corneal reflex on her right side and limited levator function in the upper 
lip during smile as shown in Figure 6.  Parent interview indicated this child exhibited typical 
cognition, language, social interactions, and acquisition of developmental milestones.  
Administration of the Goldman-Fristoe Test of Articulation 3 indicated errors for /r/, /w/, /l/ - 
expected for her age.  Test of Early Language Development 3 indicated above average receptive 
language and average expressive language as per norms for age and gender.  Errors included 
grouping items into categories, generating inferences, and differentiating between accurate and 
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inaccurate syntax – expected for her age.  Oral motor exam indicated normal tongue and jaw 
strength and speed with alternating and sequential motion tasks.  Limited lip range of motion on 
affected right side was apparent when protruding, retracting, and puckering the lips during 
alternating motion tasks.  
 
Figure 5. Participant presentation of facial palsy. From left to right: at birth, 6-weeks-old, 3-














Figure 6.  Participant presenting right facial paralysis during “smile” gesture. 
 
The participant engaged in exploratory intervention sessions which began in June 2019 
and consisted of facial imitation (pictures, clinician modeling), muscle exercises, somatosensory 
stimulation of the affected face (pneumotactile TAC-Cell), and electromyographic (EMG) 
monitoring of bilateral facial muscle groups.  By September of 2019, it was decided to provide 
the child with EMG biofeedback to facilitate facial muscle activity patterns during a variety of 
gesture productions.  EMG biofeedback sessions occurred within 15 minute sessions one time 
per week.  Three times per week (M/W/F), the participant was exposed to 20 minutes of 
pneumotactile facial stimulation in randomized blocks at saltatory velocities ranging from 5 to 
105 cm/sec.  Concurrent with pneumotactile stimulation, the participant practiced facial 
expressions with prompting. She participated in three facial gesture exercises, including ‘smile’, 
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‘kiss’, and ‘frown’.  The ‘frown’ expression was faded due to child’s emotional response, and a 
sequenced ‘smile-kiss’ expression was added. 
Electromyography.   Hydrogel surface electrodes (Kendall H124SG, 8 mm Ag/AgCl 
disc) were placed bilaterally in bipolar pairs (differential) to record from muscles groups of the 
midface (maxillary levators) and lower face (perioral) as shown in Figures 7 and 8.  
Biopotentials were conditioned by GRASS P511 amplifiers (Gain=20,000, Butterworth BP 30-
1000Hz) and digitized in real time (4,000 samples/sec, 16 bits, 5V ADC, ADInstruments 
PowerLab-16 [Colorado Springs, Colorado, USA]).  The digitized EMG signals for each of the 
four facial muscle recording sites were processed (rectified and integrated [200 ms time 
constant] in real time.  An expanded view of iEMG signals for affected and control mid-face 
electrode placements is shown in APPENDIX I.  The iEMG signals from the affected side were 
displayed in real time on a 16” HD color display monitor.  During these sessions, the participant 
was presented with clinician models of the target gesture and visuals depicted in Figure 9.  The 
stimulus visuals were presented to the participant for 20 repetitions of each expression.  The 
presentation schedule is shown in Table 2.  She was instructed to view the iEMG waveform on 
the color display with direct verbal prompts presented in between each expression.  Additional 
verbal prompts and models were provided to demonstrate facial gestures associated with ‘little’, 
‘big’, and ‘bigger’ smiles.  When the participant produced expressions in natural contexts, her 
attention was directed to the iEMG biofeedback display and her behavior was reinforced with 
positive reinforcement from the clinician.  Following each session, the iEMG signals were post-
processed to calculate the area under the iEMG waveforms over the duration of each biofeedback 
session using an absolute, non-resetting integral function expressed as µV.seconds.  A 
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normalized iEMG value was subsequently calculated for each muscle site and expressed as  


















Figure 8.  Diagram of participant and the facial electromyographic recording array for real-time 
biofeedback.  The array included 8 mm hydrogel surface electrodes configured as bipolar 
channels over the (1) right midface (R-midface), (2) right lower lip (R-LLip), (3) left midface (L-
midface), and (4) left lower lip (L-LLip).  An example of integrated EMG (iEMG) is shown in 
the left panel for muscles in the affected face, and an example of source EMG is shown in the 









Figure 9.  Stimulus prompt pictures presented to the participant by gesture type (i.e., smile and 





First 9 expressions Last 11 expressions 
‘smile’ 1) small, 2) big, 3) biggest 
expressions produced 
consecutively (x3) 
All 11 ‘smile’ expressions produced at 
biggest amplitude 
‘pucker’ 1) small, 2) big, 3) biggest 
expressions produced 
consecutively (x3) 
All 11 ‘pucker’ expressions produced at 
biggest amplitude 
‘smile-kiss’ All 20 expressions produced with ‘smile-kiss’ alternation at biggest amplitude 
 
Table 2.  Presentation schedule of stimulus prompt pictures and participant expressions. 





Statistical Processing.  Simple linear regression analyses (MTB v18.1) was used to 
characterize the relation between the normalized iEMG and session number.  Two-Sample T-
tests with 95% confidence intervals were used to test for differences between the affected (right 
face) and non-affected (left face) muscle groups, including right versus left midface, and right 
versus left lower perioral face.   
 
Results 
 The participant attended EMG and biofeedback sessions one time per week for the 
‘smile’ expression.  The final half of sessions consisted of pneumotactile sensory stimulation via 
TAC cells.  Stimulation was randomized and consisted of two rounds of 10 cycles.  The 
following data were accumulated from a series of sessions that took place at 11:00 in the 
morning in the Communication Neuroscience Laboratory (BKC 140).  The first two sessions 
occurred on Monday and Wednesday mornings and EMG biofeedback occurred on Friday 
mornings.  Two EMG baseline control sessions plus nine EMG biofeedback sessions were 
recorded over a period of 13 weeks between September 4th to November 22nd of 2020.  The total 
minutes of EMG data recording across all sessions equaled 80.5 minutes (4,828 seconds).  The 
average EMG data recording session was 7.3 minutes (439 seconds).  The integrated EMG data 
across the 11 visits are shown in Table 3. File_len is the length of the digitized data file in 
seconds.  The following columns demonstrate the EMG measurements for the right midface, 
right lip, left midface, and left lip.  These measurements are reported as integrated EMG over 
session length, and normalized to integrated EMG per second.  
The raw EMG waveform was full-wave rectified resulting in only positive measurements.  
An envelope was created from the rectified waveform and this envelope was filtered and 
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smoothed using a 0.2 sec time constant.  The area under the iEMG envelope was measured using 
a non-resetting absolute integral to calculate the total µV.s over each session recording.  The first 
column for each muscle group in Table 3 reports the total muscle bioelectric energy expressed as 
an integral (µV.s) that the participant produced for each digitized record.  Since individual 
sessions vary in duration, iEMG data records were subsequently normalized and expressed as 
µV.s/sec.  Therefore, the second column for each muscle group in Table 3 represents the 
normalized iEMG value as a function of session (visit) number. Statistical analyses were 
performed on the normalized iEMG values across sessions and muscle groups and summarized 





































*1 345 3576.5 10.37 10825.9 31.38 3859.9 11.19 5164.3 14.97 
*2 350 3120.2 8.92 8958.2 25.59 3923.4 11.21 7707.8 22.02 
3 391 4356.5 11.14 9820.4 25.12 6729.0 17.21 10790.5 27.60 
4 845 15083.0 17.85 28249.1 33.43 21931.8 25.95 34929.2 41.34 
5 554 8442.2 15.24 29263.6 52.82 11086.2 20.01 22063.4 39.83 
6 416 6495.9 15.62 15798.4 37.98 8296.1 19.94 13786.6 33.14 
7 465 6103.3 13.13 12050.1 25.91 7171.8 15.42 12363.0 26.59 
8 455 7853.0 17.26 15473.9 34.01 10720.6 23.56 15347.8 33.73 
9 405 9214.1 22.75 20772.7 51.29 10619.3 26.22 15063.8 37.19 
10 367 6147.3 16.75 13525.3 36.85 9665.4 26.34 15353.5 41.84 
11 235 4336.7 18.45 10378.1 44.16 6132.1 26.09 10639.9 45.28 
 
Table 3.  iEMG (µV.s) and normalized iEMG data (µV.s/sec) calculated for the ‘smile’ motor 
expression task across all muscle recording sites and visits.  




Figure 10.   Normalized iEMG for R-midface during ‘smile’ biofeedback gestures as a function 
of session.   
 
Simple linear regression analyses revealed that the paretic R-midface iEMG was 
significantly related to session (visit) number [F (1,9) =12.83, p=.006, R2(adj) = 54.2%] with a 
predicted positive growth in iEMG of 0.9392 µV.s/sec for each session.  Compared to baseline, 
as depicted in the first two sessions, the child participant showed a doubling of R-midface iEMG 




Figure 11.   Normalized iEMG for the non-affected L-midface during ‘smile’ biofeedback 
gestures as a function of session.   
 
The iEMG for the non-affected L-midface also shows a highly significant positive 
relation to session number [F (1,9) =14.14, p=.004, R2(adj) = 56.8%].  The predicted y-value 
(iEMG) at the 11th session was more than double in magnitude compared to session 1 (11.19 
µV.s/sec compared to 26.09 µV.s/sec, respectively).  The L-midface iEMG manifest a steeper 
slope compared to the affected R-midface iEMG (1.388 µV.s/sec versus 0.9392 µV.s/sec).  
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Figure 12.   Normalized iEMG for R-lip perioral during ‘smile’ biofeedback gestures as a 
function of session.   
 
The iEMG for the paretic R-lip perioral face is not significantly related to session number 
[F (1,9) =3.01, p=.117, R2(adj) = 16.8%].  The predicted y-value (iEMG) at the 11th session is 
somewhat higher in magnitude compared to session 1 (31.38 µV.s/sec compared to 44.16 
µV.s/sec, respectively), but this apparent difference is not significant which is consistent with 
large variation in the data and a small R-square of 16.8%.  This is consistent with less significant 





Figure 13.   Normalized iEMG for the non-affected L-lip perioral during ‘smile’ biofeedback 
gestures as a function of session.   
 
The iEMG for the non-affected L-lip perioral face shows a highly significant positive 
relation to session number [F (1,9) =11.11, p=.009, R2(adj) = 50.3%].  The predicted y-value 
(iEMG) at the 11th session is triple in magnitude compared to session 1 (14.97 µV.s/sec 
compared to 45.28 µV.s/sec, respectively).  The L-lip perioral iEMG manifest a steeper slope 
compared to the affected R-lip perioral iEMG (2.101 µV.s/sec versus 1.47 µV.s/sec).  
To compare the effected right side to the non-affected left side, two sample t-tests were 
conducted using a 95% confidence interval.  Comparing the right midface to the left midface, 
yielded the following results: t-value = 2.35, df = 17, and p-value = 0.031 indicating a significant 
effect.  The right lower lip and left lower lip comparison yielded the following results: t-value of 
0.78, df = 19, and p-value = 0.444 indicating no significant effect.  
 22 
Discussion 
Persistent idiopathic facial paralysis often presents variable reanimation given various 
treatment techniques.  In this study, real-time iEMG biofeedback was shown to promote 
increased levels of muscle activation and observed reanimation in an individual with persistent 
idiopathic facial paralysis.  This quantitative physiological measurement and intervention can be 
compared to facial grading systems which are subjective in nature (Duarte-Moreiera et al., 2018; 
Kasahara et al., 2017; Lee et al., 2015; Pourmomeny et al., 2013).  The results provide evidence 
of the positive effects of biofeedback for reanimation of the participant’s affected mid-face.  
Regression analyses revealed the strong positive relation between voluntary iEMG levels among 
muscle groups in the affected (paralytic) face and session number.  On average, our 3-year old 
female participant achieved a growth in Right mid-face iEMG of 0.9392 µV.s/sec for each 
session, with more than half of the variance in her EMG production accounted for by this 
regression function [R2(adj) = 54.2%].   The positive growth in iEMG levels each week of 
therapy also demonstrated that the treatment effect was greater than chance.  On average, our 
participant achieved a growth in the right lower lip iEMG of 1.470 µV.s/sec for each session, 
however less than half of the variance in her EMG production could be accounted for by this 
regression function [R2 (adj) = 16.8%.].   These findings align with previous studies indicating 
the efficacy of biofeedback for increasing movement and reanimation following paralysis and the 
variance in results (de Freitas et al., 2016, Maia et al., 2019).  During the treatment period, the 
clinical researchers noted observable changes in the participant’s face including the appearance 
of a dimple on the participant’s right side and increased movement such as the ability for the 
participant to furrow her eyebrows.  Additionally, the participant’s dentist, who was blind to the 
research procedure, commented on perceived increases in the participant’s facial range of 
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motion.  These observations indicate the subjective yet practical changes which occurred during 
the treatment period.  Upon post-interview 11 months following the final EMG and biofeedback 
session, the participant’s parents indicated that they had not observed any further changes in her 
facial movement.  Per clinician observation, the participant maintains asymmetry when 
producing expressions and does not have the corneal reflex provided with external stimulants 
(i.e., snapping near the eye). It should be noted that the participant exhibits eye closure and 
reflexes when provided with pneumotactile sensory stimulation in the orbital region. However, 
no objective measures were taken to determine longevity of treatment effects.  They also indicate 
no solidified treatment plan given the global pandemic and subsequent discontinuation of 
biofeedback sessions and interventions.  The participant continues to participate in activities 
which maintain her quality of life including dance and school.  
  From parent report, medical records, and iEMG analyses it is possible that the 
participant’s orofacial musculature and anatomy has regressed due to a loss/reduction of facial 
motor nerve input, including atrophy of zygomatic facial muscle groups which are necessary to 
produce a full smile and oral angle retraction.  The extent of orofacial muscular atrophy could be 
determined using 3T MRI.  Further neuroimaging was previously recommended by the 
participant’s otolaryngologist following inability to visualize the facial nerve course due to 
opacification of the mastoid.  Increasing the iEMG electrode montage over putative mid-face 
zygomatic and buccinator muscle groups would be useful to increase the resolution of muscle 
activation fields.  Increasing the number of recording sites and decreasing the size of bipolar 
iEMG recording fields (interelectrode distance) may provide additional electrophysiological 
information regarding the participant’s specific areas of paresis and yield further comparisons 
with the unaffected side.  Although not appropriate for pediatric applications due to its invasive 
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nature, the use of 40 µm hook-wire intramuscular electrodes would greatly improve the 
selectivity of muscle recordings to help better define the location and extent of intact facial 
muscle groups on the paretic side.    
 
Limitations of this Clinical Study   
The present report, based on clinical study of a 3-year old child with idiopathic unilateral 
facial palsy, demonstrated the potent therapeutic effects of real-time EMG biofeedback over the 
course of 11 weeks in a clinical speech physiology laboratory using simple non-invasive 
electrophysiological methods to facilitate growth in muscle activation levels among affected 
muscle groups during repetition of functional motor behaviors (i.e., smile, pucker, etc.).  Further 
research is required to investigate the effects of biofeedback across populations using larger 
sample sizes.  The global pandemic (COVID-19) prevented a formal test of EMG biofeedback 
on reanimation of facial motor control in this 3-year old female presenting with unilateral 
idiopathic facial palsy.  Thus, the electrophysiological data and observations about facial 
animation presented in this report are based on EMG and somatosensory stimulation presented 
during the course of clinical intervention with this child over a period of 11 weeks during the 
Fall semester 2019.  The student investigator successfully created a UNL approved IRB Human 
Subjects protocol, but the sudden onset of COVID-19 prevented the initiation and completion of 
this study to test effects of iEMG biofeedback in combination with somatosensory interventions 
on reanimation of the paralytic face.   
Even in the clinical setting, it is recommended that recording procedures be more 
controlled (e.g., time between expressions, further training to the concept of biofeedback, 
consistent placement of electrodes, etc.).  These limitations may be remediated through further 
 25 
conditioning sessions with the participant, and clear demonstration that a child participant of this 
age is able to comprehend the use of biofeedback.  Future directions for this study participant 
include continuing with pneumotactile stimulation to investigate effectiveness in reanimating the 
affected mid-face to improve facial animation (i.e., smile, lip retraction).   
Clinical interventions aimed to develop/restore facial animation would benefit from a 
detailed case history, including craniofacial and neuroimaging data to better understand the 
presence or absence of facial muscle groups, and delineation of the presence/absence of facial 
nerve branches, and congenital anomalies at or near cranial/facial skeleton foramen which may 
have contributed to malformation of the peripheral distribution of the facial nerve in this child.  
This may also determine her candidacy for a more invasive treatment such as a nerve and muscle 
graft to restore facial kinematics, used in conjunction with EMG biofeedback and somatosensory 
therapies.  This procedure was previously mentioned by the participant’s pediatric plastic 
surgeon and is pending possible reevaluation after the participant turns five years old.  The 
participant’s parents indicated their preference to avoid invasive procedures when noninvasive 
ones are accessible and efficacious.  These options alone, demonstrate the range of treatment 
options available to individuals with facial palsy and the complex decision-making process that 
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Expanded view of electromyographic records from the affected (red) and non-affected (blue) 
mid-face facial muscles.  Raw unprocessed EMG records are shown in the top panel, and the 
rectified and integrated EMG (time constant = 200 ms) display used for real time biofeedback on 







 Two-Sample T-Test and CI:  








Sample	 N	 Mean	 StDev	 SE	Mean	
EMG-R-midface_n	 11	 15.22	 4.06	 1.2	
EMG-L-midface_n	 11	 20.29	 5.89	 1.8	














Two-Sample T-Test and CI:  







Sample	 N	 Mean	 StDev	 SE	Mean	
EMG-R-LIP_n	 11	 36.23	 9.74	 2.9	
EMG-L-LIP_n	 11	 33.05	 9.38	 2.8	




































Analysis of Variance 
Source	 DF	 SS	 MS	 F	 P	
Regression	 1	 97.027	 97.0272	 12.83	 0.006	
Error	 9	 68.042	 7.5602	 			 			
Total	 10	 165.069	 			 			 			












Analysis of Variance 
Source	 DF	 SS	 MS	 F	 P	
Regression	 1	 237.757	 237.757	 3.01	 0.117	
Error	 9	 710.072	 78.897	 			 			
Total	 10	 947.829	 			 			 			




















Analysis of Variance 
Source	 DF	 SS	 MS	 F	 P	
Regression	 1	 211.953	 211.953	 14.14	 0.004	
Error	 9	 134.914	 14.990	 			 			
Total	 10	 346.867	 			 			 			












Analysis of Variance 
Source	 DF	 SS	 MS	 F	 P	
Regression	 1	 485.652	 485.652	 11.11	 0.009	
Error	 9	 393.266	 43.696	 			 			
Total	 10	 878.918	 			 			 			
Fitted Line: EMG-L-LIP_n versus SESSION 
 
 
     
